Skip to main content
. 2021 Sep 28;394(11):2343–2346. doi: 10.1007/s00210-021-02156-5

Fig. 3.

Fig. 3

Incorrect and corrected forest plots for mean reductions in MMD from baseline to week 12 with quarterly versus monthly fremanezumab dosing in patients with episodic migraine